HMGN proteins are architectural chromatin proteins that reduce the compaction of the chromatin fiber, facilitate access to nucleosomes and modulate replication and transcription processes. Here we demonstrate that in Xenopus laevis, the expression and cellular location of the HMGN proteins are developmentally regulated and that their misexpression leads to gross developmental defects in post-blastula embryos. HMGN transcripts and proteins are present throughout oogenesis; however, the proteins stored in the cytoplasm are not associated with lampbrush chromosomes, and are rapidly degraded when oocytes mature into eggs. During embryogenesis, HMGN expression is first detected in blastula stages and progresses to a tissue-specific expression reaching relative high levels in the mesodermal and neuroectodermal regions of tadpoles. Only after midblastula transition (MBT), alterations in the HMGN levels by either microinjection of recombinant proteins or by morpholino-antisense oligo treatments produced embryos with imperfectly closed blastopore, distorted body axis and showed abnormal head structures. Analyses of animal cap explants indicated that HMGN proteins are involved in the regulation of mesoderm specific genes. In addition, HMGN misexpression caused altered expression of specific genes at MBT rather than global changes of transcription rates. Our results demonstrate that proper embryonic development of Xenopus laevis requires precisely regulated levels of HMGN proteins and suggest that these nucleosomal binding proteins modulate the expression of specific genes. q
Introduction
In most multicellular organisms, the tissue-specific patterns of gene expression are established early in embryogenesis. The transcriptional level of specific genes is partially regulated by their chromatin structure and by the activity of nuclear proteins that remodel and change the structure of the chromatin fiber (reviewed by Patterton and Wolffe, 1996) . For example, Xenopus eggs and early preblastula embryos contain the maternal histone H1 variant named H1M or B4 (Smith et al., 1988) and are deficient in somatic histone H1 (Dimitrov et al., 1993; Hock et al., 1993; Dworkin-Rastl et al., 1994) . At midblastula transition (MBT), concomitant with the onset of transcription of the embryonic genome, H1M is gradually substituted by three somatic histone H1 variants. This developmentally regulated expression of the histone H1 gene family is known to be involved in the selective repression of oocyte 5S rRNA genes (Kandolf, 1994; Bouvet et al., 1994) and in the selective silencing of regulatory genes required for mesodermal differentiation (Steinbach et al., 1997) .
Non-histone proteins such as the high mobility group (HMG) proteins, which are associated with the chromatin fiber, might also contribute to the regulation of transcriptional activity during Xenopus development. The HMG proteins are among the most abundant and ubiquitous nonhistone proteins found in nuclei of higher vertebrates. By binding to their DNA or chromatin targets these proteins induce specific chromatin conformations that facilitate and enhance DNA-related activities such as transcription and replication (Bustin and Reeves, 1996; Bustin, 1999) . The HMG protein family is divided into three subfamilies: the HMGB 1 subfamily, the HMGA 1 subfamily and the HMGN 1 subfamily (Bustin, 1999 (Bustin, , 2001a . The expression of HMGB during Xenopus embryogenesis has been studied in detail (Kleinschmidt et al., 1983; Ura et al., 1996; Nightingale et al., 1996) . HMGB gradually accumulates during Xenopus oogenesis and is highly abundant in chromatin of early embryonic stages. Embryonic Xenopus HMGB seems to play a structural role in organizing the linker DNA in the nucleosomal array Ura et al., 1996) . HMGN transcripts have been detected in Xenopus (Gawantka et al., 1998) . However, their developmental expression has not yet been studied and their role in developmental processes is not known. The highly conserved HMGN chromosomal proteins are the only nuclear proteins that specifically bind to the nucleosome core particle (reviewed by Bustin, 2001b) . It has been suggested that HMGN proteins are involved in the generation, or maintenance, of a chromatin structure that is unique to transcriptional active genes (Weisbrod, 1982) . Indeed, the binding of HMGN proteins to nucleosomes reduces the compaction of the chromatin fiber and facilitates transcriptional processes (Crippa et al., 1993; Ding et al., 1994 Ding et al., , 1997 Paranjape et al., 1995; Trieschmann et al., 1995a,b; Bustin et al., 1995; Tremethick and Hyman, 1996; Hock et al., 1998a) . Using confocal immunofluorescence we have demonstrated that HMGN2 and active transcription sites colocalize to the same chromatin domains (Hock et al., 1998a) .
Results from a variety of experimental systems indicate that the transcription of HMGN-genes and the cellular levels of HMGN proteins change during differentiation processes such as erythropoiesis , myogenesis (Begum et al., 1990) , osteoblast differentiation (Shakoori et al., 1993) and kidney organogenesis (Lehtonen and Lehtonen, 2001) . It was also shown that aberrant expression of HMGN1 affects differentiation of myoblasts (Pash et al., 1993) and that depletion of HMGN proteins from mouse oocytes interfered with cell cleavage and delayed the timing needed to reach the blastocyst stage (Mohamed et al., 2000) .
The above-mentioned studies indicate a correlation between HMGN expression and cellular differentiation; however, it is not yet clear whether these proteins are involved in the regulation of genes relevant for embryonic development or in differentiation processes. To get insights into the role of HMGN proteins in cellular differentiation and embryonic development we investigated the expression pattern, distribution, and function of these proteins in Xenopus laevis. We found that the expression and intracellular localization of HMGN proteins are developmentally regulated and that experimental manipulations of the intracellular levels of HMGN protein caused specific developmental defects. Significantly, our results suggest that HMGN proteins modulate the expression of specific genes involved in the regulation of development. The results show, for the first time, that these ubiquitous nucleosomal binding proteins affect not only the compactness of the chromatin fiber but also modulate the expression of specific genes.
Results

Xenopus HMGN proteins
Comparative sequence analysis of the Xenopus ESTclone database with the known sequences of human HMGN1 and HMGN2 revealed two EST-clones, termed 11G6 and 12G2 (Gawantka et al., 1998) which seemed to encode Xenopus HMGN orthologues. RT-PCR and primer extension of Xenopus mRNA resulted in full length cDNAs with deduced amino acid sequences that shared high similarities with HMGN1 and HMGN2 proteins described in other species. The functional domains characteristic for the HMGN protein family, i.e. the bipartite nuclear localization signal, the nucleosomal binding domain, and the chromatin unfolding domain, were identical in Xenopus, human, mouse and chicken (Fig. 1) . The high degree of sequence conservation suggests that Xenopus HMGN (XHMGN) proteins function like their orthologues from other species.
Cytoplasmic localization of HMGN protein during oogenesis
Northern blot analysis revealed the presence of XHMGN mRNAs in all oocyte stages ( Fig. 2A) . The apparent decrease of the signal strength does not necessarily indicate a drop of XHMGN mRNA abundance during oocyte growth. Since equal RNA quantities were loaded per lane, these mRNAs are progressively diluted in the RNA samples by the massive accumulation of ribosomal RNAs, beginning with stage II/III oocytes. Western blots of perchloric acid (PCA) extracts from oocytes revealed the presence of XHMGN1 and XHMGN2 proteins in all oocyte stages (Fig. 2B) . However, oocytes matured by progesterone treatment did not contain detectable amounts of XHMGN1 and XHMGN2 proteins indicating that both proteins are rapidly degraded during oocyte maturation (Fig. 2B , lane E). Quite surprisingly, HMGN proteins were found exclusively in the cytoplasm of oocytes and were undetectable by immunoblot analyses in manually isolated germinal vesicles (Fig. 2C ). This finding was unexpected since the lampbrush chromosomes of growing oocytes are transcriptionally highly active and HMGN proteins are considered a hallmark of transcriptionally active chromatin, at least in somatic cells (Hock et al., 1998a) . Since a relative small population of chromosome bound HMGN proteins might have gone undetected by immunoblot analyses of isolated oocyte nuclei, we probed lampbrush chromosome spreads by immunofluorescence microscopy using antibodies directed against XHMGN1 and XHMGN2. Both antibodies failed to label the lampbrush chromosomes (results obtained with antibodies to XHMGN1 are shown in Fig. 2D , a-a 00 ). It should be emphasized that both antibodies used are suitable for immunlocalization studies. Thus, they stained the nuclei of Xenopus A6 cells (not shown) and of post-blastula embryos (see Fig. 3B ). Furthermore, the chromatin of spread lampbrush chromosomes is readily accessible to antibodies as indicated by their bright fluorescence after reaction with antibodies directed against core histones (Hock et al., 1993; Morgan, 2002) . The apparent absence of HMGN proteins from the lampbrush chromosomes can be explained by the exclusion of these proteins from the oocyte nucleus or their inability to bind to chromatin of lampbrush chromosomes. To clarify this issue we injected fluorescent labeled XHMGN1 into oocyte nuclei. Two hours later, lampbrush chromosomes were spread and analyzed by fluorescence microscopy. As shown in Fig. 2D (b) , the lampbrush chromosomes fluoresced brightly under these conditions demonstrating their potential to interact with HMGN proteins. It is interesting to note that injection of exogenous HMGN proteins did not interfere with transcriptional events as judged from the unaltered morphology of the lampbrush chromosome loops, in striking contrast to the effects of microinjected histone H1 (Hock et al., 1993) .
Tissue-specific HMGN expression during embryogenesis
Our finding that in oocytes HMGN proteins are cytoplasmic and that during oocyte maturation the proteins are degraded suggests that XHMGN proteins are not maternally stored during oogenesis and are not involved in structuring chromatin in early embryos. Indeed, by Western blot analyses and immunofluorescence studies XHMGN proteins were first detected in blastula embryos (Fig. 3A,B) . A similar expression pattern has been described for the somatic histone variant H1A (Dimitrov et al., 1993; Hock et al., 1993; Dworkin-Rastl et al., 1994) . As a control, we therefore reprobed the blot with antibodies to histone H1A. In agreement with previous studies, histone H1A was detectable from the blastula stage onward (Fig. 3A) . In Northern blots using total RNA from five embryos each, XHMGN transcripts were also first detected in blastula embryos (Fig. 4A ). Both HMGN genes were found to be expressed throughout neurula and tadpole embryos (Fig. 4B, a,b ) consistent to what was described by Gawantka et al. (1998; see also www.dkfz-heidelberg.de/abt0135/ axeldb.htm) . Particularly high expression levels were seen in somitogenic mesoderm-and neuroectoderm-derived regions (Fig. 4B, c -f ). These tissue-specific differences in expression levels were also found by RT-PCR, using RNA isolated from different regions of dissected NF25/26 embryos (Fig. 4C) .
Taken together, our analyses of the HMGN gene expression during Xenopus development suggest that the appearance and distribution of XHMGN proteins is fine tuned during oogenesis and early embryogenesis, with a cytoplasmic localization in oocytes, disappearance at maturation and reappearance in blastula stage embryos. Landsman et al., 1989) , mouse-HMGN1 (mHMGN1, Landsman and Bustin, 1990 ) and chicken-HMGN1 (chHMGN1, Dodgson et al., 1988) . (Lower part) Amino acid sequence comparison of Xenopus-HMGN2 (XHMGN2) with human-HMGN2 (hHMGN2, Landsman et al., 1986) , mouse-HMGN2 (mHMGN2, Landsman et al., 1988a) and chicken-HMGN2 (chHMGN2, Landsman et al., 1988b) . The shaded areas indicate the major functional domains of the HMGN proteins: bipartite nuclear localization signals (NLS1 and NLS2), nucleosomal binding domain and C-terminal chromatin unfolding domain (chud). Amino acid identities are represented by ( p ), conservative amino acid substitutions by (:) and semi-conservative substitutions by (.). Similarities are indicated in %. Note the high conservation of the functional domains.
2.4. Alterations of HMGN protein levels do not interfere with pre-blastula development or assembly of bulk chromatin Our finding that the expression and cellular location of HMGN proteins are regulated raises the possibility that these proteins play a role in Xenopus development. To test this possibility, we either elevated or decreased the HMGN protein amounts in embryos using recombinant proteins or morpholino antisense oligos. To increase the embryonic HMGN levels, highly purified human HMGN proteins (Fig. 5A) were injected into the zygote. As controls, we injected the double point mutant HMGN1S20,24E protein, which enters the nucleus but does not bind to nucleosomes or chromatin (Prymakowska-Bosak et al., 2001) .
Western blot analyses revealed that injected HMGN proteins were stable in embryos and caused an increased HMGN pool at least until the gastrula-stage (Fig. 5B) . To reduce HMGN protein levels, morpholino antisense oligomeres (MoHMGN) were injected into the zygote. Western blots indicate that injection of 20 ng MoHMGN2 into the zygote significantly reduced the HMGN2 protein level in the early gastrula-stage embryos (Fig. 5B) .
Neither overexpression nor depletion of HMGN proteins showed any effect on timing of cleavage as revealed by time lapse imaging (shown for HMGN2 in Fig. 5C ).
32 P-UTP, co-injected together with MoHMGN2 or HMGN proteins, was incorporated into newly synthesized zygotic RNA at the same developmental stage (Fig. 5D) . In all experiments, incorporation of radioactivity into heterogeneous RNA was observed , 5.5 h post-fertilization (arrow in Fig. 5D ). Onset of bulk zygotic transcription was neither promoted in HMGN injected embryos, nor delayed in MoHMGN2 injected embryos. Comparison of bulk chromatin revealed no differences in wild type, HMGN injected or MoHMGN2 injected embryos (Fig. 6 ). Chromatin was isolated from wild type or manipulated stage 9 embryos and digested with micrococcal nuclease. The digestion patterns showed neither effects on nucleosomal spacing nor effects on nuclease-accessibility of bulk chromatin (Fig. 6A) . Similarly, we did not observe changes in bulk chromatin structure at the light microscopical level in gastrula cells expressing HMGN-EGFP fusion proteins after injection of expression vectors into the zygote (Fig. 6B ). The chromatin structure was indistinguishable in wild type cells or cells overexpressing HMGN2-EGFP (Fig. 6B ). Together these experiments suggest that manipulation of HMGN levels does not interfere with cleavage events, does not change a time shift of zygotic transcriptional activation and does not change global chromatin structure.
Manipulation of HMGN protein levels cause malformations in post-blastula development
Since HMGN proteins are expressed after the MBT it is possible that these proteins function at later developmental stages. Indeed, in HMGN injected embryos, developmental defects became evident in late gastrulae (NF13 Table 1 ). This indicates that chromatin interaction of HMGN proteins, and not the protein per se, was responsible for the induced phenotypes.
Interestingly, depletion of HMGN2 by injection of morpholino antisense oligonucleotides produced very similar developmental defects (44 out of 47 cases; Fig In each lane PCA extracted proteins from 15 eggs or embryos were analyzed. The embryonic stages analyzed are indicated above each lane (Nieuwkoop and Faber, 1975; NF) . Nitrocellulose filters were incubated with antibodies to XHMGN1 and XHMGN2 (see legend to Fig. 2C ), stripped again and finally probed with antibodies directed to histone H1A. As a loading control the corresponding Ponceau S stained nitrocellulose is shown. The protein bands at 33 kD (arrow) represent nucleoplasmin (Hock et al., 1993) . The prominent lower bands at ,13 kD most likely represent PCA extracted core histones (Kleinschmidt et al., 1983) . (B) Immunofluorescence microscopy of paraffin sections using XHMGN2 specific antibodies (a, b). XHMGN2 is detectable in all nuclei of the blastula stage embryo. Blastocoel (bc); animal region (an). Bar represents 20 mm in (a) and 60 mm in (b).
HMGN proteins modulate the expression of regulatory genes
In somatic cells the average amount of HMGN proteins can only bind to less than 5% of the nucleosomes. In addition, the proteins are only transiently associated with chromatin and move rapidly throughout the entire nucleus (Hock et al., 1998a; Phair and Misteli, 2000) . Thus, it is not surprising that HMGN-induced global changes in chromatin structure or overall transcription rates are not easily detectable even when the HMGN level is increased. We therefore asked whether alterations in HMGN levels would affect transcription of specific genes. To search for such genes we used the animal cap assay. Exposure of animal cap explants to activin induces the expression of specific genes and diverts the differentiation of the animal cap cells from ectodermal to mesodermal cell types (Smith et al., 1990; Gurdon et al., 1994 Gurdon et al., , 1995 . Animal caps loose their competence to respond to activin approximately 10.5 h post-fertilization (h.p.f.; Jones and Woodland, 1987; Grainger and Gurdon, 1989 ).
To test whether alterations in HMGN protein levels affect the expression of mesoderm specific genes we cultured animal caps isolated from control and HMGN2 injected sibling blastulae (NF8) for various times, and then exposed them to 5 ng/ml activin for 12 h at 24 8C (Fig. 9A) . Mesoderm induction was monitored morphologically by elongation of animal caps (Symes and Smith, 1987) and by RT-PCR analyses of mesoderm specific gene expression. As expected, control explants ceased to elongate 10.5 h.p.f. (Fig. 9B, upper panel) . In contrast, in HMGN-injected embryos elongation was observed until 11.5 h.p.f. (Fig. 9B , lower panel). In agreement, RT-PCR analyses revealed that in the injected embryos mesoderm specific genes like XmyoD, Xbra and a-actin were induced until 11.5 h.p.f. compared to 10.5 h.p.f. in control siblings (Fig. 9C) . Essentially the same results were obtained after injection of HMGN1 (Fig. 9D) . Significantly, in control experiments with animal caps isolated from embryos injected with the HMGN1S20,24E double mutant, the time frame of mesodermal competence was not affected and loss of mesodermal competence occurred at 10.5 h.p.f. as in control (C) NF25/26 embryos were dissected as indicated in the cartoon into mesoderm/neural tube (3, red), brain/head (2, yellow), endoderm (4, green) and ectoderm/skin (1). RNA was isolated from dissected tissues and probed for HMGN1 or HMGN2 expression by RT-PCR. The expression of the pan-neural marker NRP-1 and the mesodermal marker XmyoD were used to show the enrichment of respective tissues in the embryonic fractions. As a control, the expression of the constitutively expressed translation elongation factor EF1-a is shown. Note the elevated expression levels of HMGN1 and HMGN2 in neural and mesodermal tissues. siblings (Fig. 9E) . These results imply that the interaction of HMGN proteins with chromatin interferes with the expression of mesoderm specific genes in induced animal caps and that a functional nucleosomal binding domain is needed for this interference.
Since HMGN gene transcription commences at MBT, we investigated whether experimentally induced alterations in HMGN protein levels would interfere with the transcription of specific regulatory genes at MBT. Based on the results with the animal cap assay we focused on regulatory genes involved in mesoderm differentiation and analyzed the onset of transcription of selected genes by RT-PCR (Fig. 10) . Onset of expression of Xnr3, Xnr5, follistatin and chordin was identical in control and HMGN injected siblings (Fig. 10A) . Expression of Xbra was slightly promoted in HMGN injected embryos. More strikingly, injection of morpholinos clearly delayed the expression of Xbra for 1 h as compared to controls (Fig. 10B) . In contrast, expression of chordin was promoted for at least 1 h in HMGN depleted embryos (Fig. 10B) . The onset of the expression of Xnr3, Xnr5 and follistatin was identical in Wt and MoHMGN injected embryos. These results suggest that HMGN proteins modulate the expression of specific genes at MBT such as Xbra and chordin.
Discussion
The ubiquitous occurrence of HMGN proteins in vertebrates and their ability to modulate the architecture and function of chromatin (reviewed by Bustin, 2001a,b) raises the possibility that they play a role in developmental and differentiation processes. We used the Xenopus laevis system to gain insight into the cellular distribution and possible function of the HMGN proteins during embryonic development. The major new findings described in this manuscript are: (1) the expression and cellular location of the HMGN proteins are regulated during development; (2) the levels of HMGN proteins are critical for proper 
Xenopus HMGN proteins
Xenopus HMGN (XHMGN) proteins are very similar to previously described vertebrate HMGN proteins from other vertebrate species (for refs. see legend to Fig. 1 ). The sequence conservation is especially striking in the functional domains, i.e. the nuclear localization signal, the nucleosomal binding domain and the chromatin unfolding domain (Fig. 1) . This high degree of sequence conservation across species argues for an important and conserved function in vertebrates. Furthermore, the presence of both HMGN1 and HMGN2 in all vertebrates suggests a distinct and non-interchangeable function of these proteins.
Expression of HMGN proteins during Xenopus oogenesis and embryogenesis
During oogenesis HMGN-mRNAs and HMGN proteins were found to be present in all oocyte stages. Unexpectedly we were unable to localize the HMGN proteins in the oocyte nuclei, neither by Western blot experiments using manually isolated nuclei, nor by immunocytochemistry using spread lampbrush chromosomes. Instead, HMGN proteins were found in the cytoplasm of oocytes. The apparent exclusion of the HMGN proteins from the oocyte nuclei contrasts with the distribution of HMGB proteins, which accumulate both in the cytoplasm and in the nucleus of amphibian oocytes (Kleinschmidt et al., 1983) . Thus, it is unlikely that HMGN proteins play a critical role for the architecture and transcription of lampbrush chromosomes. This is supported by our observation that upon microinjection into oocytes, exogenous HMGN proteins bind to lampbrush chromosomes without affecting the lateral loops, which harbor the transcription units of protein coding genes. We have observed neither loop retraction which is known to accompany transcriptional inactivation nor loop extension which is indicative of facilitated transcriptional processes (Morgan, 2002) . The molecular mechanism, which retains HMGN proteins in the cytoplasm and prevents their accumulation in the oocyte nuclei is not known. HMGN contain an NLS (Hock et al., 1998b) and therefore would be expected to be imported into the nucleus. From our results that exogenous HMGN proteins will bind to lampbrush chromosomes when delivered into the oocyte nucleus we can conclude that their nuclear exclusion in oocytes must be an active process and is not caused by the unavailability of chromatin binding sites. Recently we found that in somatic cells HMGN proteins are phosphorylated during the mitotic prophase, leave the chromatin and are retained in the cytoplasm of newly formed daughter cells by binding to 14-3-3 proteins (Prymakowska-Bosak et al., 2002) . It is conceivable that a similar mechanism may contribute to the retention of the HMGN proteins in the cytoplasm of oocytes.
Interestingly, in progesterone-treated oocytes HMGN proteins are no longer detectable, indicating that they are rapidly degraded during maturation. A similar behavior has also been described for other proteins (Kneissel et al., 2001 ). Thus, HMGN proteins do not belong to the class of maternal proteins which are stored in the egg for future embryonic growth and development. Indeed, HMGN proteins are absent from early embryonic stages and their synthesis commences after MBT. The temporal coincidence between the appearance of the HMGN proteins and transcriptional activation of the embryonic genome at MBT is consistent with their proposed role in the unfolding of compact higher order structures of the chromatin fiber (Crippa et al., 1993; Ding et al., 1997; Paranjape et al., 1995; Trieschmann et al., 1995a,b; Bustin et al., 1995) .
The temporal regulation of HMGN protein expression during Xenopus development closely resembles the expression of somatic histone H1A (Dimitrov et al., 1993; Hock et al., 1993) . A similar correlated occurrence of HMGN proteins and histone H1 has also been noted during mouse development (Mohamed et al., 2000; Adenot et al., 2000) . Interestingly, the nucleosomal footprint of HMGN DNA was isolated and electrophoresed on a 2% agarose gel, which was subsequently stained with EtBr. Lanes marked M contain 1 mg of a 100 bp DNA ladder (MBI). Mono-, di-and trinucleosomes are marked by asterisks. Note that the micrococcal nuclease digestion pattern is essentially identical in manipulated and control embryos. (B) Squash preparation of a gastrula (NF12) which was injected with a HMGN2-EGFP expression plasmid into the zygote. Only one of the three nuclei shown contains detectable amounts of the fluorescent fusion protein (arrow in a). HMGN2-EGFP was expressed in a mosaic. Overall nuclear organization and chromatin structure appears identical between HMGN2-EGFP expressing (arrow) and wild-type cells (arrowheads) as judged from the Hoechst staining (a 0 ).
Bar corresponds to 10 mm.
proteins partially overlaps with that of histone H1 (Alfonso et al., 1994) , suggesting that HMGN proteins may affect the interaction of linker histones with chromatin (Bustin, 1999 (Bustin, , 2001b . Indeed, in an SV40 minichromosome model system HMGN1 relieves the histone H1 mediated transcriptional repression (Ding et al., 1997) and in living cells, HMGN proteins and histone H1 compete for the same chromatin binding sites . Thus, the developmental expression of HMGN proteins may be timed to coincide with a requirement for efficient, regulated transcription from H1-containing chromatin.
Manipulating the HMGN protein levels
To gain insight into the functional role of HMGN proteins during development, we manipulated the HMGN protein levels in embryos. Prior to MBT embryonic development was not affected. Neither overexpression nor depletion influenced cleavage, global chromatin structure and the onset of embryonic gene expression. This was unexpected, since previous investigations of mouse embryogenesis revealed that HMGN-depleted chromatin caused a delay and reduction of overall embryonic transcription during the pre-implantation stage (Mohamed et al., 2000) . Similarly, displacement of HMGN proteins from chromatin caused reduced transcription in human cells (Hock et al., 1998a) . A major difference between the Xenopus and the mouse system is that in the former HMGN proteins are not detected prior to MBT. Thus, when the proteins are not present they are non-functional and alterations in their levels do not have any functional consequences.
Whereas cleavage and onset of embryonic transcription occurred normally, altered HMGN protein levels interfered with later development. Thus, once the proteins are synthesized and functional, their levels have to be monitored tightly. The majority of embryos showed imperfect closure of the blastopore and when reaching the tadpole stages they displayed a distorted and shortened body axis with microcephalic and acephalic phenotypes. In neurula stage embryos, aggregates of dead cells were often located in the vitelline space. Although previous studies suggested that these abnormalities are due to apoptosis (Grammer et al., 2000) , our comparative whole-mount TUNEL assays failed to support this conclusion. Conceivably, the HMGN proteins interfere with gastrulation movements, leading to an imperfect closure of the blastopore. As a consequence, some mesodermal and endodermal cells die externally near the remaining blastopore.
It is highly significant that injection of the point-mutated HMGN1S20,24E, which lacks the functional nucleosomal binding domain (Prymakowska-Bosak et al., 2001 ) did not affect embryonic development. This observation demonstrates that it is not the mere presence of HMGN proteins, but rather the specific interaction with chromatin, which is incompatible with normal development. Depletion of XHMGN2 by injection of antisense-morpholinos (Mo-HMGN2) resulted in malformations with similar characteristics seen in HMGN-injected embryos but with a prominent dorsalization in earlier stages. Co-injection of 300 pg of HMGN2 protein along with Mo-HMGN2 rescued these phenotypes. This amount of co-injected HMGN2 protein corresponds to the calculated amount of HMGN proteins present in , 5000 somatic cells, i.e. the cell number of a blastula (a Xenopus cell contains 6 pg chromosomal DNA; assuming a DNA/histone mass ratio of 1:1 in chromatin and an abundance of 1% HMGN, one cell contains 0.06 pg and 5000 cells 300 pg of HMGN proteins). Notably, rescue experiments using a tenfold higher amount of HMGN2 protein (3 ng) caused phenotypes comparable to HMGN2-injection, supporting our conclusion that the exact HMGN protein levels are important for proper development. Deviation from precise and critical HMGN levels lead to imperfect closure of the blastopore and distorted body axis. Since axis formation is one of earliest processes requiring the expression of specific regulatory factors in defined quantities, it is conceivable that HMGN proteins modulate the expression of some of these factors.
HMGN proteins interfere with expression of specific genes
In activin-induced isolated animal caps, HMGN proteins interfered with the expression of mesoderm specific genes.
Compared to sibling controls, animal caps of HMGNinjected embryos showed a prolonged mesodermal competence and mesoderm specific genes like XMyoD, Xbra and a-actin were inducible for a longer time period. Significantly, this effect is linked to the ability of the protein to bind to nucleosomes since the mutant HMGN1S20,24E had no effect on mesodermal gene expression. We also noted that activin treatment of animal caps caused an increased transcription of HMGN genes and a decreased HMGN Fig. 9 . Injected recombinant HMGN2 proteins interfere with expression of mesoderm-specific genes in activin-induced animal caps. (A) Experimental design: animal caps were isolated from experimental or control sibling blastulae (NF8). After 0.5-7.5 h incubation in buffer (corresponding to 6 -13 h postfertilization; h.p.f.) the explants were treated for 12 h with 5 ng/ml activin, followed by morphological examination or RNA isolation and RT-PCR analyses. (B) HMGN injection prolongs mesodermal competence. Elongation of control (upper panel) and HMGN-injected animal cap explants (lower panel) induced by activin exposure. (C) Loss of mesodermal competence of animal caps isolated from HMGN2-injected or control blastulae as studied by RT-PCR. The time window of activin responsiveness of XmyoD, Xbra and a-actin genes (indicated at the right) is prolonged as compared to the sibling controls. In the absence of activin the genes are not activated (last lane, no activin). Histone H3 is constitutively expressed and serves as a control. (D,E) Prolongation of mesodermal competence requires the nucleosome binding domain of HMGN. Experiments were performed as described in (A) except that recombinant HMGN1 (D) or the double point mutant HMGN1S20,24E was injected which does not bind to nucleosomes (E).
expression accompanied the loss of mesodermal competence (not shown). These results suggest that HMGN proteins not only interfere with expression of mesoderm specific genes but may also play a role in establishing mesodermal competence.
Histone H1 has a rate limiting effect on the loss of mesodermal competence (Steinbach et al., 1997) apparently because the onset of synthesis of somatic histone H1 in post-blastula embryos inactivates the expression of genes involved in mesodermal differentiation, such as XMyoD and Xbra. Our finding that HMGN proteins showed the opposite effect (Fig. 9C,D) provides additional support for a possible functional interplay between these two chromatin binding proteins in living cells and raises the possibility that such an interplay plays a role in establishing the time window of mesodermal competence.
Our finding that HMGN proteins affect the expression of specific genes at MBT provides additional support for a role of HMGN in modulating specific gene expression. The genes affected, Xbra and chordin, could lead to the observed phenotypes (Sasai et al., 1994; Mochizuki et al., 2000) . The exact mechanism whereby HMGN proteins affect the expression of specific genes is not presently clear. One possibility is that HMGNs bind to specific regions as part of multiprotein complexes . Alternatively the fast movement of HMGN proteins throughout the entire nucleus and their transient interactions with nucleosomes is part of the mechanism that regulates the access of transcription factors to their cognate binding sites. Alterations in the levels of HMGN proteins changes the accessibility of these factors to their sites and changes the transcription levels of specific genes like Xbra. On the other hand the altered transcription of chordin can be considered as an indirect downstream effect. Xbra interferes with the expression of transcription factors (Mochizuki et al., 2000) that are involved in suppression of chordin expression (Sasai et al., 1994) . Thus, the precocious chordin expression found in HMGN depleted embryos could be a downstream effect caused by the delayed expression of Xbra. It is conceivable that HMGN proteins interfere with the transcription of further regulatory genes not yet identified in a similar correlative or indirect way. In concert, this influence on the expression of regulatory genes could then lead to the extreme phenotypes observed. Together, our data link HMGN proteins and specific gene expression in early Xenopus embryogenesis and extends the regulation of the expression of developmentally regulatory genes to architectural elements that modulate the higher order structure of the chromatin fiber. 
Experimental procedures
Antibodies, proteins and antisense oligos
Antibodies against XHMGN1 were raised in rabbit against the peptides PKRKQVNADVADAKD. In Western blots these antibodies recognize a 5% PCA extractable polypeptide of oocytes cells and Xenopus post-blastula embryos with an apparent molecular mass of 19 kD (Fig. 2B) . Furthermore, the antibodies bound specifically to GST-XHMGN1 when probed on Western blots (Fig. 2B) . Antibodies to XHMGN2 were raised against the peptide PKRKADGDSKAEKAK and reacted in Western blots specifically with a 17 kD polypeptide or GST-XHMGN2 (Fig. 2B ). For controls polyclonal rabbit antibodies to Xenopus H1A (Moorman and de Boer, 1985; Hock et al., 1993) , antibodies directed to the conserved nucleosomal binding domain of HMGN proteins (Hock et al., 1998a) and antibodies directed to nucleoplasmin (Kleinschmidt et al., 1985) were used. The production of recombinant human HMGN proteins and of the double point mutated HMGN1S20,24E (Prymakowska-Bosak et al., 2001 ) and fluorescent labeling of the HMGN1S88C mutant (Hock et al., 1998b) have been described. Morpholino antisense oligos were purchased from Gene Tools LLC (USA). The sequence of the HMGN2 antisense oligo was 5 0 -CCTTTCTCTTGGGCATTGTTGGCTG-3 0 . For controls, the 'Morpholino Standard Control' oligo with the sequence 5 0 -CCTCTTACCTCAGTTACAATTTATA-3 0 was used.
Handling and manipulation of oocytes and embryos
Small ovary pieces were removed from anesthetized Xenopus laevis females and placed in modified Barth's medium (Peng, 1991) . For maturation, ovary pieces were incubated in the presence of progesterone (Sigma) at a final concentration of 10 mg/ml for 2 h and then kept in Barth's medium for further 12 h. Follicle cells were removed as described (Hock et al., 1993) . Oocytes were staged according to Dumont (1972) , injected into the nucleus with 5 ng fluorescein-labeled HMGN1 and lampbrush chromosomes prepared 2 h later, essentially as described by Callan et al. (1987) . Immunofluorescence on lampbrush chromosomes with XHMGN antisera at a 1:100 dilution was as described (Hock et al., 1996) . For biochemical fractionation, stage IV/V oocytes were manually dissected into germinal vesicles and cytoplasmic portions, and separately collected in 5% PCA for protein extraction.
In vitro fertilization of eggs and culture of embryos was performed as described (Hock et al., 1993) . Embryos were kept at 24 8C and staged according to Nieuwkoop and Faber (1975) . For microinjections prior to the first cleavage, embryos were dejellied in 2% cysteine 45 min after fertilization and placed in 5% MMR (1 £ MMR: 100 mM NaCl, 2 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 5 mM Hepes pH 7.4). Unless otherwise indicated, the following amounts were injected per zygote: 3 ng of protein, 20 ng of morpholino oligos and 0.4 mCi a-32 P-UTP (800 Ci/mmol; ICN), respectively. For expression of HMGN2-EGFP (Phair and Misteli, 2000; Lührs et al., 2002) , 100 pg of linearized plasmid (Afl II; New England Biolabs, Germany) was injected. As controls, sibling embryos were mock injected with buffer or control proteins as indicated. Squash preparations were prepared from early gastrulae in buffer containing Hoechst 33258. Fluorescence pictures were taken with a Zeiss Axiophot equipped with a digital camera (PixelFly). For mesoderm induction animal caps (explanted at NF8) were incubated in RPMI 1640 (Gibco) supplemented with 5 ng/ml recombinant human activin (R&D Systems, Wiesbaden, Germany) for 12 h. Sibling populations were processed for RT-PCR.
Sequence of XHMGN1, XHMGN2 and RT-PCR
Xenopus HMGN2 cDNA was obtained by RT-PCR. Embryonic RNA (NF25) was used for the reverse transcription and PCR-amplified using the primers 5 0 -ATGCCCAAGAGAAAGGCTGAC-3 0 and 5 0 -TCACG-CTTCACTTTGTGTCCC-3 0 . These primers correspond to the 5 0 -and 3 0 -ends of the putative HMGN2 coding region of EST-clone 12G2 (AI031240, Gawantka et al., 1998) .
Xenopus HMGN1 was isolated by 3 0 -RACE using the SMARTe cDNA library construction kit (Clontech) for first strand synthesis. For PCR the primers 5 0 -ATGCCTAA-GAGAAAGCAGGTAAACGCT-3 0 (corresponding to the 5 0 region of the putative coding region of EST-clone 11G6; AI031226, Gawantka et al., 1998) and 5 0 -ATTCTAGAGGCCGAGGCGGCCGACATG10x(TTT)VN-3 0 were used. The PCR products were cloned by Topo TA Cloning w (Invitrogen) and sequenced. The deduced coding sequence for HMGN1 was:
The deduced coding sequence for HMGN2 was:
Animal-cap RNA was isolated with TriFaste (Peqlab, Erlangen, Germany) as described by the manufacturer. For reverse transcription, 1 mg of isolated RNA was used. The primer sets for brachyury (Xbra), XMyoD, a-actin, follistatin and chordin were chosen from www.lifesci.ucla. edu/hhmi/derobertis/index.html. The primers for Xnr3 and Xnr5 were from Yang et al. (2002) . Primers for histone H3 (XH3), 410 bp, forward 5 0 -ATGGCTCGTACTAAGCA-GACCGC-3 0 , reverse 5 0 -CTAAGCCTCTCGCCTCGGAT-3 0 were chosen from the sequence X72950 and were amplified with 25 cycles as suggested for other primers used for various histone genes (see www site above). Primers for the pan-neural marker NRP-1 and primers for the constitutively expressed translation elongation factor EF1-a were chosen from Hemmati-Brivanlou and Melton (1994) . For all primer sets annealing was at 55 8C with 25 cycles, except for EF1-a and HMGN1 with 20 cycles.
PCA-extraction and Western blot analysis
Proteins were extracted from oocytes or embryos collected in 5% PCA, and the extracted proteins were acetone precipitated as described (Hock et al., 1993) , washed with 70% acetone and resuspended in 1 £ RotiLoad (Roth) for gel electrophoresis in 15% acrylamide gels containing SDS. Western blot procedures were as described (Hock et al., 1998a) , except that in the case of XHMGN1 detection, blocking and dilution of the first antibody was with TBS containing 0.1% Tween-20 (Sigma).
Paraffin embedding and immunofluorescence
Dejellied embryos were fixed in Carnoy (75% methanol and 25% acetic acid) for at least 3 h at room temperature, dehydrated in 100% ethanol at room temperature for 2 h, immersed in tertiary butanol at 40 8C for 1 h, and embedded in paraplast (Lancer, USA) using standard procedures. Sections were deparaffinated and rehydrated as described (Hock et al., 1993) , treated with antigen unmasking solution (Vector) as described by the manufacturer, and used for immunofluorescence. The XHMGN-specific sera were diluted 1:100 and incubated overnight at 4 8C. Washing of paraffin sections, detection of bound antibodies and mounting was as described (Hock et al., 1993) . Immunofluorescence on lampbrush chromosomes was as described (Hock et al., 1996) .
In vitro RNA synthesis and Northern blot analysis
Digoxigenin labeled antisense RNA probes were produced with an in vitro transcription kit (Roche, Mannheim, Germany) using the linearized plasmids containing the cloned coding sequences of XHMGN1 or XHMGN2 as templates.
For RNA isolation, 10 embryos were lysed in 1 ml TriFast and processed according to the manufacturers protocol (PeqLab, Erlangen, Germany). RNA gel electrophoresis was performed as described (Hock et al., 1998a) . Separated RNAs were transferred onto a nylon membrane, UV-crosslinked, and the membrane prehybridized for 1 h at 55 8C in hybridization solution containing 50% formamide, 5 £ SSC, 0.1% N-laurylsarcosine, 0.02% SDS and 5% blocking reagent (Roche, Mannheim, Germany). Membranes were hybridized overnight at 55 8C in hybridization solution containing 50 ng/ml digoxigenin labeled probe, washed 2 £ 15 min with 2 £ SSC/0.1% SDS at room temperature, and 2 £ 15 min with 0.1 £ SSC/0.1% SDS at 55 8C. Bound probes were detected either with digoxigenin specific antibodies coupled to alkaline phosphatase and NBT/BCIP or antibodies coupled to peroxidase (Roche, Mannheim, Germany) and enhanced chemical luminescence (ECL, Amersham, Braunschweig, Germany) as indicated.
Whole-mount in situ hybridization
For whole-mount analysis the embryos were fixed for 2 h at room temperature in MEMFA (0.1 M MOPS, pH 7.4, 2 mM EGTA, 1 mM MgSO 4 , 3.7% formaldehyde), transferred to MEMFA:methanol (1:1) for 2-3 min, and stored in 100% methanol at 2 20 8C until use.
Whole-mount in situ hybridization was performed as described by Harland (1991) with pre-hybridization for 2 h followed by hybridization overnight at 50 8C using 100 ng of a dig-labeled RNA probe. For photographic documentation, the embryos were also dehydrated and cleared by incubation in benzylalcohol/benzylbenzoate 2:1 for 15-30 min as indicated.
Analysis of chromatin structure
Nuclei of late blastulae (NF9) were isolated as described (Menut et al., 1999) and digested with 0.7 U/ml micrococcal nuclease (MBI) for 10 min at 24 8C. Digested chromatin was treated with RNase A (Sigma) and proteinase K (Sigma). The DNA was phenol extracted and analyzed on 2% agarose gels.
